Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Díez Campelo M, Sánchez-Barba M, de Soria VG, Martino R, Sanz G, Insunza A, Bernal T, Duarte R, Amigo ML, Xicoy B, Tormo M, Iniesta F, Bailén A, Benlloch L, Córdoba I, López-Villar O, Del Cañizo MC; Spanish Registry of MDS.. Results of allogeneic stem cell transplantation in the Spanish MDS registry: prognostic factors for low risk patients. Leuk Res. 2014 Oct;38(10):1199-206. doi: 10.1016/j.leukres.2014.07.009. PubMed PMID: 25139847.
AÑO: 2014; IF: 2.351
25139847
van 't Wout EF, Dickens JA, van Schadewijk A, Haq I, Kwok HF, Ordóñez A, Murphy G, Stolk J, Lomas DA, Hiemstra PS, Marciniak SJ. Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z ?1-antitrypsin. Hum Mol Genet. 2014 Feb 15;23(4):929-41. doi: 10.1093/hmg/ddt487. PubMed PMID: 24097797; PubMed Central PMCID: PMC4007119.
AÑO: 2014; IF: 6.393
24097797
Jiménez MJ, Ferra C, García O, de Arriba F, Jiménez S, Insunza A, Calabuig M, Mantecon A, Sánchez J, Torres M, Balsalobre P, Linio J, Jiménez A, Feliu E, Ribera JM. The commitment and evaluation of the quality management plan by professionals from accredited stem cell transplant centers in Spain. Bone Marrow Transplant. 2014 Jul;49(7):990-2. doi: 10.1038/bmt.2014.85. PubMed PMID: 24777187.
AÑO: 2014; IF: 3.57
24777187
González-Billalabeitia E, Seitzer N, Song SJ, Song MS, Patnaik A, Liu XS, Epping MT, Papa A, Hobbs RM, Chen M, Lunardi A, Ng C, Webster KA, Signoretti S, Loda M, Asara JM, Nardella C, Clohessy JG, Cantley LC, Pandolfi PP. Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition. Cancer Discov. 2014 Aug;4(8):896-904. doi: 10.1158/2159-8290.CD-13-0230. PubMed PMID: 24866151; PubMed Central PMCID: PMC4125493.
AÑO: 2014; IF: 19.453
24866151
Gimenez E, Besses C, Boque C, Velez P, Kerguelen A, Cervantes F, Ferrer-Marin F, Perez-Encinas M, Rodriguez M, Gonzalez JD, Calzada R, Hernandez-Boluda JC. Indirect and non-medical economic burden, quality-of-life, and disabilities of the myelofibrosis disease in Spain. J Med Econ. 2014 Jun;17(6):435-41. doi: 10.3111/13696998.2014.903257. PubMed PMID: 24716650.
AÑO: 2014
24716650
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL